Clinical Trials
701 trialsComparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Eastern Cooperative Oncology Group
DCP-NDM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
H. Lee Moffitt Cancer Center and Research Institute
Multicentric Database for KRAS Mutant Pancreatic Cancer
Fudan University
The Canopy Cancer Collective Clinical Registry Protocol
Canopy Cancer Collective, LLC
DCP-DM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
National Institutes of Health Clinical Center (CC)
DESCENT-1
A2 Biotherapeutics Inc.
LEARN
University of Sydney
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
Imperial College London
ОС26
Military Medical Clinical Center of the Southern Region, Ukraine
K4CARE-PDAC
Chang Gung Memorial Hospital
VAPOR
Imperial College London
KITuKo
Medizinische Hochschule Brandenburg Theodor Fontane
PSR for SPN
Fudan University
Predicting Disease Progression and/or Recurrence in Cancer
Massachusetts General Hospital
Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
National Institutes of Health Clinical Center (CC)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
PREDIPER
Assistance Publique - Hôpitaux de Paris
Pancreatic Cancer Genetics
Columbia University
iCaRe2
University of Nebraska
EXCEED
AstraZeneca
PREDICT-PANC
Medical College of Wisconsin
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
University of Missouri-Columbia
DP-04
AstraZeneca
A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data
Shanghai Zhongshan Hospital
BASECAMP-1
A2 Biotherapeutics Inc.
MRinRT
Swansea Bay University Health Board
Map HPB
University of Nottingham
PATAKESS
Centre Leon Berard
Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer
West Virginia University
Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET Imaging
Ruijin Hospital
Predicting Effective Therapy in Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
MiPac
St. Antonius Hospital
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
SJFAMILY
St. Jude Children's Research Hospital
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Mayo Clinic
PRECEDE
Arbor Research Collaborative for Health
PRONPaC
Medizinische Hochschule Brandenburg Theodor Fontane
CONVERCAP
Institut Bergonié
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
University of Maryland, Baltimore
MIND-PANC
Shanghai Zhongshan Hospital
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
Nuvance Health
PANDOME
Nuvance Health
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Nuvance Health
TraveraRTGx
Travera Inc
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
UroPanc
Queen Mary University of London
Collection of Circulating Biomarkers in Pancreatic Cancer
Abramson Cancer Center at Penn Medicine